Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer

Overview of attention for article published in Frontiers in oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,770 followers.

Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer. https://t.co/NW9Ca6c7JQ

RT @AndrewZloza: Congrats! to @gupta__vineet of @RushDOIM and @RushCancer at @RushMedical and his amazing team who discovered "Positive All…

RT @AndrewZloza: Congrats! to @gupta__vineet of @RushDOIM and @RushCancer at @RushMedical and his amazing team who discovered "Positive All…

Congrats! to @gupta__vineet of @RushDOIM and @RushCancer at @RushMedical and his amazing team who discovered "Positive Allosteric Modulation of #CD11b as a Novel Therapeutic Strategy Against #LungCancer" using @GossamerBio wonder drug, #GB1275. https://t.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.